ERBB2 and breast carcinoma: Different molecular subtypes of breast cancer, such as Luminal A, Luminal B, HER2-rich breast cancer, and triple-negative breast cancer (TNBC), exhibit diverse clinical behaviors, possess disparate prognoses, and necessitate tailored therapeutic approach [4].